Do you know how to use immune checkpoint inhibitors to treat a variety of hematologic malignancies? Test yourself with our latest quiz.
Hematologic Malignancies Quiz
Can you name biomarkers that are associated with PCNS-DLBCL? Are you aware of contraindications for use of rituximab in DLBCL? Test your knowledge by taking this multiquestion quiz.
What are appropriate sources of stem cells for HCT in patients without an HLA-matched, related donor? Is post-transplant cyclophosphamide–based haploidentical donor transplantation appropriate for racial and ethnic minority patients with hematologic cancers? Test your knowledge with this multiquestion quiz.
Which agents are associated with increased risk of sarcomas in childhood leukemia? What are the most common secondary cancers among survivors of childhood leukemias, lymphomas, and other childhood malignancies? Take this multiquestion quiz to find out.
Do you know which molecular markers signify poor-risk disease in AML? And how about what makes AML a challenging disease to manage in older adult patients? Test your knowledge in our latest quiz.
Which genetic mutation confers shorter progression-free survival in myelofibrosis patients undergoing allogeneic stem cell transplantation? And what is the only potentially curative treatment for primary myelofibrosis? Test your knowledge in our latest quiz.
What is the real-world economic burden associated with complications from hematopoietic cell transplantation? What prognostic factors for posttransplantation outcomes among patients with chronic myelomonocytic leukemia are significant predictors of survival? Answer these and more in our latest quiz.
When should patients be vaccinated after a bone marrow transplantation? What agent might be considered as a new chemotherapy option in younger patients with AML in first remission? Test your knowledge in our latest quiz.
In the first blinatumomab trial, what percentage of pediatric ALL patients achieved a complete remission? What is the effect of vitamin D and calcium supplementation on bone mineral density in the pediatric ALL population? Test your knowledge in our latest quiz.
What is the optimal duration of treatment for patients with CML before stopping tyrosine kinase inhibitors? Can a fecal occult blood test detect dasatinib-induced hemorrhagic colitis? Test your knowledge in our latest quiz.